How do we interpret the sample data?

A. Cortot (Lille, France)

Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Session: PG17 Lung cancer: the issue with the tissue
Session type: Postgraduate Course
Number: 145

WebcastSlide presentationPDF journal article, handout or slidesMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Cortot (Lille, France). How do we interpret the sample data?. International Congress 2014 – PG17 Lung cancer: the issue with the tissue

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How do we interpret the results?
Source: Annual Congress 2006 - Blood gas workshop
Year: 2006


Analysing the data
Source: ERS Course 2015
Year: 2015



Neither questions nor answers, just original data
Source: Eur Respir J 2003; 21: 377
Year: 2003


How can real-world data be used to improve outcomes?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021



Application of big data technology for COVID-19: Primary care big data
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

How to interpret microbiological results
Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Year: 2014




How should tumour sample analysis be applied to patient management?
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014




A data management and analysis platform for RASP-UK multiomics clinical datasets
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021



More than just a study subject?
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013

Is data quality more important than data quantity in the diagnosis of occupational asthma from serial PEF records?
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010

How to use monitoring data to make wise clinical decisions
Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients
Year: 2015

Defining successful NIV setup: data from a real-life cohort
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


What have we learn from rebiospy studies?
Source: ERS Research Seminar
Year: 2015


Who do we exclude if we only consider subjects with excellent quality spirometry?Analysis of UK Biobank longitudinal data.
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing
Source: ERJ Open Res, 4 (1) 00108-2017; 10.1183/23120541.00108-2017
Year: 2018



What makes large epidemiological studies comparable?
Source: Eur Respir J 2010; 36: 720-721
Year: 2010